COMPASS PATHWAYS PLC Basic Shares Outstanding (Weighted Average)
COMPASS PATHWAYS PLC (CMPS) reported Basic Shares Outstanding (Weighted Average) of 135.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 135.04M shares, a 44.67% increase year-over-year.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 110.06M shares, a 23.40% increase year-over-year.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 96.08M shares, a 39.39% increase year-over-year.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 95.34M shares, a 39.39% increase year-over-year.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for fiscal 2025 was 93.50M shares, a 38.56% increase from fiscal 2024.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for fiscal 2024 was 67.48M shares, a 32.25% increase from fiscal 2023.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for fiscal 2023 was 51.03M shares, a 20.25% increase from fiscal 2022.
- COMPASS PATHWAYS PLC weighted average number of shares outstanding, basic for fiscal 2022 was 42.44M shares, a 6.10% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 135.04M shares 10-Q · filed 2026-08-05 | 122.68M shares 10-Q · filed 2026-08-05 | 113.73M shares derived: average of 3 quarters · filed 2026-08-05 | 109.13M shares derived: average of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | 110.06M shares 10-Q · filed 2026-05-13 | 103.07M shares derived: average of 2 quarters · filed 2026-05-13 | 100.49M shares derived: average of 3 quarters · filed 2026-05-13 | 98.71M shares derived: average of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | 96.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 95.71M shares derived: average of 2 quarters · filed 2026-03-24 | 94.92M shares derived: average of 3 quarters · filed 2026-08-05 | 93.50M shares 10-K · filed 2026-03-24 | |
| 2025-09-30 | 95.34M shares 10-Q · filed 2025-11-04 | 94.34M shares derived: average of 2 quarters · filed 2026-08-05 | 92.65M shares 10-Q · filed 2025-11-04 | 86.70M shares derived: average of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | 93.34M shares 10-Q · filed 2026-08-05 | 91.28M shares 10-Q · filed 2026-08-05 | 83.82M shares derived: average of 3 quarters · filed 2026-08-05 | 79.96M shares derived: average of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | 89.19M shares 10-Q · filed 2026-05-13 | 79.06M shares derived: average of 2 quarters · filed 2026-05-13 | 75.51M shares derived: average of 3 quarters · filed 2026-05-13 | 73.72M shares derived: average of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | 68.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 68.66M shares derived: average of 2 quarters · filed 2026-03-24 | 68.56M shares derived: average of 3 quarters · filed 2026-03-24 | 67.48M shares 10-K · filed 2026-03-24 | |
| 2024-09-30 | 68.40M shares 10-Q · filed 2025-11-04 | 68.38M shares derived: average of 2 quarters · filed 2025-11-04 | 67.00M shares 10-Q · filed 2025-11-04 | 65.76M shares derived: average of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | 68.37M shares 10-Q · filed 2025-07-31 | 66.30M shares 10-Q · filed 2025-07-31 | 64.88M shares derived: average of 3 quarters · filed 2025-07-31 | 61.07M shares derived: average of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | 64.22M shares 10-Q · filed 2025-05-08 | 63.13M shares derived: average of 2 quarters · filed 2025-05-08 | 58.63M shares derived: average of 3 quarters · filed 2025-05-08 | 55.37M shares derived: average of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | 62.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 55.84M shares derived: average of 2 quarters · filed 2025-02-27 | 52.41M shares derived: average of 3 quarters · filed 2025-02-27 | 51.03M shares 10-K · filed 2025-02-27 | |
| 2023-09-30 | 49.63M shares 10-Q · filed 2024-10-31 | 47.60M shares derived: average of 2 quarters · filed 2024-10-31 | 47.36M shares 10-Q · filed 2024-10-31 | 45.13M shares derived: average of 4 quarters · filed 2024-10-31 | |
| 2023-06-30 | 45.57M shares 10-Q · filed 2024-08-01 | 44.15M shares 10-Q · filed 2024-08-01 | 43.63M shares derived: average of 3 quarters · filed 2024-08-01 | 43.36M shares derived: average of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | 42.73M shares 10-Q · filed 2024-05-08 | 42.67M shares derived: average of 2 quarters · filed 2024-05-08 | 42.62M shares derived: average of 3 quarters · filed 2024-05-08 | 42.58M shares derived: average of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | 42.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 42.57M shares derived: average of 2 quarters · filed 2024-02-29 | 42.54M shares derived: average of 3 quarters · filed 2024-02-29 | 42.44M shares 10-K · filed 2024-02-29 | |
| 2022-09-30 | 42.53M shares 10-Q · filed 2023-11-02 | 42.50M shares derived: average of 2 quarters · filed 2023-11-02 | 42.38M shares 10-Q · filed 2023-11-02 | 42.22M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | 42.47M shares 10-Q · filed 2023-08-03 | 42.11M shares 10-Q · filed 2023-08-03 | 42.12M shares derived: average of 3 quarters · filed 2024-02-29 | 42.02M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | 42.04M shares 10-Q · filed 2023-05-11 | 41.95M shares derived: average of 2 quarters · filed 2024-02-29 | 41.87M shares derived: average of 3 quarters · filed 2024-02-29 | 41.35M shares derived: average of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | 41.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 41.78M shares derived: average of 2 quarters · filed 2024-02-29 | 41.12M shares derived: average of 3 quarters · filed 2024-02-29 | 40.00M shares 10-K · filed 2024-02-29 | |
| 2021-09-30 | 41.71M shares 10-Q · filed 2022-11-03 | 40.76M shares derived: average of 2 quarters · filed 2022-11-03 | 39.38M shares 10-Q · filed 2022-11-03 | 38.53M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | 39.80M shares 10-Q · filed 2022-08-04 | 38.19M shares 10-Q · filed 2022-08-04 | 37.47M shares derived: average of 3 quarters · filed 2023-02-28 | 38.53M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | 36.57M shares 10-Q · filed 2022-05-10 | 36.31M shares derived: average of 2 quarters · filed 2023-02-28 | 38.11M shares derived: average of 3 quarters · filed 2023-02-28 | 38.53M shares derived: average of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | 36.05M shares derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | 38.88M shares derived: average of 2 quarters · filed 2023-02-28 | 39.19M shares derived: average of 3 quarters · filed 2023-02-28 | 16.99M shares 10-K · filed 2023-02-28 | |
| 2020-09-30 | 41.71M shares 10-Q · filed 2022-11-03 | 12.83M shares 6-K · filed 2021-11-09 | 40.76M shares derived: average of 2 quarters · filed 2022-11-03 | 10.64M shares 6-K · filed 2021-11-09 | |
| 2020-06-30 | 39.80M shares 10-Q · filed 2022-08-04 | 9.87M shares 6-K · filed 2021-08-11 | 9.53M shares 6-K · filed 2021-08-11 | ||
| 2019-12-31 | 7.48M shares 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |